304 related articles for article (PubMed ID: 11694246)
21. Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine.
Darwish HM; El-Khatib FF; Ayesh S
Hemoglobin; 2005; 29(2):119-32. PubMed ID: 15921164
[TBL] [Abstract][Full Text] [Related]
22. Correction of aberrant pre-mRNA splicing by antisense oligonucleotides in beta-thalassemia Egyptian patients with IVSI-110 mutation.
El-Beshlawy A; Mostafa A; Youssry I; Gabr H; Mansour IM; El-Tablawy M; Aziz M; Hussein IR
J Pediatr Hematol Oncol; 2008 Apr; 30(4):281-4. PubMed ID: 18391696
[TBL] [Abstract][Full Text] [Related]
23. Molecular Characterization of β-Thalassemia Intermedia in Southeast Iran.
Miri-Moghaddam E; Bahrami S; Naderi M; Bazi A; Karimipoor M
Hemoglobin; 2016 Jun; 40(3):173-8. PubMed ID: 27117567
[TBL] [Abstract][Full Text] [Related]
24. Molecular basis of β-thalassemia in the United Arab Emirates.
Baysal E
Hemoglobin; 2011; 35(5-6):581-8. PubMed ID: 22074124
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of alpha-thalassemia determinants, beta-thalassemia alleles, and beta S haplotypes among Kuwaiti Arabs.
Adekile AD; Gu LH; Baysal E; Haider MZ; al-Fuzae L; Aboobacker KC; al-Rashied A; Huisman TH
Acta Haematol; 1994; 92(4):176-81. PubMed ID: 7701914
[TBL] [Abstract][Full Text] [Related]
26. Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study.
Kolliopoulou A; Siamoglou S; John A; Sgourou A; Kourakli A; Symeonidis A; Vlachaki E; Chalkia P; Theodoridou S; Ali BR; Katsila T; Patrinos GP; Papachatzopoulou A
Hemoglobin; 2019 Jan; 43(1):27-33. PubMed ID: 31039620
[TBL] [Abstract][Full Text] [Related]
27. Treatment of beta-thalassemia with hydroxyurea (HU)--effects of HU on globin gene expression.
Huang SZ; Ren ZR; Chen MJ; Xu HP; Zeng YT; Rodgers GP; Zeng FY; Schechter AN
Sci China B; 1994 Nov; 37(11):1350-9. PubMed ID: 7865126
[TBL] [Abstract][Full Text] [Related]
28. Study of the RNA splicing defect in the common Chinese beta-thalassemia gene, IVS-II nt. 654 C-->T by using mRNA/PCR.
Huang SZ; Ren ZR; Zeng YT; Zeng FY; Rodgers GP; Schecter AN
Sci China B; 1992 Oct; 35(10):1232-7. PubMed ID: 1285849
[TBL] [Abstract][Full Text] [Related]
29. [Molecular diagnosis in a Korean family with thalassemia intermedia due to co-inheritance of triplicated alpha-globin genes (alphaalpha/alphaalphaalpha(anti 3.7)) and beta-thalassemia trait (IVS-II-1 G-->A)].
Chen M; Han JY; Sun Q; Kim IH; Ren Z; Huang S; Zeng Y
Zhonghua Xue Ye Xue Za Zhi; 2000 Apr; 21(4):195-7. PubMed ID: 11876981
[TBL] [Abstract][Full Text] [Related]
30. A novel mutation of -73(A-->T) in the CCAAT box of the beta-globin gene identified in a patient with the mild beta-thalassemia intermedia.
Chen XW; Mo QH; Li Q; Zeng R; Xu XM
Ann Hematol; 2007 Sep; 86(9):653-7. PubMed ID: 17516066
[TBL] [Abstract][Full Text] [Related]
31. Beta-thalassemia intermedia in Turkey.
Altay C; Gürgey A
Ann N Y Acad Sci; 1990; 612():81-9. PubMed ID: 2291577
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and genetic analysis of α-thalassemia and β-thalassemia in Chongqing area of China.
Yao XY; Yu J; Chen SP; Xiao JW; Zheng QC; Liu HY; Zhang L; Xian Y; Zou L
Gene; 2013 Dec; 532(1):120-4. PubMed ID: 24055728
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization and PCR detection of a deletional HPFH: application to rapid prenatal diagnosis for compound heterozygotes of this defect with beta-thalassemia in a Chinese family.
Xu XM; Li ZQ; Liu ZY; Zhong XL; Zhao YZ; Mo QH
Am J Hematol; 2000 Nov; 65(3):183-8. PubMed ID: 11074532
[TBL] [Abstract][Full Text] [Related]
34. Molecular studies of beta-thalassemia heterozygotes with raised Hb F levels.
Vrettou C; Kanavakis E; Traeger-Synodinos J; Metaxotou-Mavrommati A; Basiakos I; Maragoudaki E; Stamoulakatou A; Papassotiriou I; Kattamis C
Hemoglobin; 2000 Aug; 24(3):203-20. PubMed ID: 10975440
[TBL] [Abstract][Full Text] [Related]
35. [Beta-thalassemia mutations and single nucleotide polymorphism at -158 of Ggamma-globin gene associated with altered levels of Hb F in beta-thalassemia heterozygotes].
Chen JF; Long GF; Lin WX; Chen P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):498-501. PubMed ID: 15476181
[TBL] [Abstract][Full Text] [Related]
36. Different hematological phenotypes caused by the interaction of triplicated alpha-globin genes and heterozygous beta-thalassemia.
Camaschella C; Kattamis AC; Petroni D; Roetto A; Sivera P; Sbaiz L; Cohen A; Ohene-Frempong K; Trifillis P; Surrey S; Fortina P
Am J Hematol; 1997 Jun; 55(2):83-8. PubMed ID: 9209003
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis of beta thalassemia in the south of Thailand.
Laosombat V; Fucharoen SP; Panich V; Fucharoen G; Wongchanchailert M; Sriroongrueng W; Nopparatana C; Kenpitak K; Maipang M; Fukumaki Y
Am J Hematol; 1992 Nov; 41(3):194-8. PubMed ID: 1415194
[TBL] [Abstract][Full Text] [Related]
38. Humanized beta-thalassemia mouse model containing the common IVSI-110 splicing mutation.
Vadolas J; Nefedov M; Wardan H; Mansooriderakshan S; Voullaire L; Jamsai D; Williamson R; Ioannou PA
J Biol Chem; 2006 Mar; 281(11):7399-405. PubMed ID: 16421096
[TBL] [Abstract][Full Text] [Related]
39. The phenotypic and molecular diversity of hemoglobinopathies in India: A review of 15 years at a referral center.
Nadkarni AH; Gorakshakar AC; Sawant PM; Italia KY; Upadhye DS; Gorivale MS; Mehta PR; Hariharan P; Ghosh K; Colah RB
Int J Lab Hematol; 2019 Apr; 41(2):218-226. PubMed ID: 30489691
[TBL] [Abstract][Full Text] [Related]
40. Distinct phenotypic expression associated with a new hyperunstable alpha globin variant (Hb heraklion, alpha1cd37(C2)Pro>0): comparison to other alpha-thalassemic hemoglobinopathies.
Traeger-Synodinos J; Papassotiriou I; Metaxotou-Mavrommati A; Vrettou C; Stamoulakatou A; Kanavakis E
Blood Cells Mol Dis; 2000 Aug; 26(4):276-84. PubMed ID: 11042028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
